Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where DCGO declined for three days, in 273 of 303 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DCGO as a result. In 79 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for DCGO turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 41 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.
The Aroon Indicator for DCGO entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where DCGO's RSI Indicator exited the oversold zone, 27 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where DCGO advanced for three days, in 187 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
DCGO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.224) is normal, around the industry mean (204.132). P/E Ratio (-0.139) is within average values for comparable stocks, (18.957). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.100) among similar stocks. P/S Ratio (0.127) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. DCGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DCGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
USPH broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In 26 of the 35 cases the stock fell afterwards. This puts the odds of success at 74%.
The 10-day RSI Indicator for USPH moved out of overbought territory on October 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 27 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where USPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on USPH as a result. In 55 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for USPH just turned positive on October 22, 2026. Looking at past instances where USPH's MACD turned positive, the stock continued to rise in 28 of 42 cases over the following month. The odds of a continued upward trend are 67%.
Following a +2.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where USPH advanced for three days, in 217 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 159 of 254 cases where USPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. USPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.870) is normal, around the industry mean (204.132). USPH's P/E Ratio (507.529) is considerably higher than the industry average of (18.957). Projected Growth (PEG Ratio) (2.823) is also within normal values, averaging (2.498). Dividend Yield (0.021) settles around the average of (0.100) among similar stocks. P/S Ratio (1.556) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. USPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
DCGO | USPH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 61 | 89 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 45 Fair valued | 97 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 90 | |
PRICE GROWTH RATING 1..100 | 93 | 42 | |
P/E GROWTH RATING 1..100 | 8 | 1 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DCGO's Valuation (45) in the null industry is somewhat better than the same rating for USPH (97) in the Medical Or Nursing Services industry. This means that DCGO’s stock grew somewhat faster than USPH’s over the last 12 months.
DCGO's Profit vs Risk Rating (100) in the null industry is in the same range as USPH (100) in the Medical Or Nursing Services industry. This means that DCGO’s stock grew similarly to USPH’s over the last 12 months.
USPH's SMR Rating (90) in the Medical Or Nursing Services industry is in the same range as DCGO (98) in the null industry. This means that USPH’s stock grew similarly to DCGO’s over the last 12 months.
USPH's Price Growth Rating (42) in the Medical Or Nursing Services industry is somewhat better than the same rating for DCGO (93) in the null industry. This means that USPH’s stock grew somewhat faster than DCGO’s over the last 12 months.
USPH's P/E Growth Rating (1) in the Medical Or Nursing Services industry is in the same range as DCGO (8) in the null industry. This means that USPH’s stock grew similarly to DCGO’s over the last 12 months.
| DCGO | USPH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 84% | 1 day ago 71% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 72% |
| Momentum ODDS (%) | 1 day ago 89% | 1 day ago 71% |
| MACD ODDS (%) | 1 day ago 87% | 1 day ago 67% |
| TrendWeek ODDS (%) | 1 day ago 88% | 1 day ago 68% |
| TrendMonth ODDS (%) | 1 day ago 88% | 1 day ago 68% |
| Advances ODDS (%) | 1 day ago 75% | 11 days ago 66% |
| Declines ODDS (%) | 4 days ago 90% | 4 days ago 67% |
| BollingerBands ODDS (%) | 1 day ago 83% | 1 day ago 74% |
| Aroon ODDS (%) | 1 day ago 88% | 1 day ago 63% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DCGO’s FA Score shows that 1 FA rating(s) are green while USPH’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DCGO’s TA Score shows that 4 TA indicator(s) are bullish while USPH’s TA Score has 4 bullish TA indicator(s).
DCGO (@Hospital/Nursing Management) experienced а -2.21% price change this week, while USPH (@Hospital/Nursing Management) price change was +3.20% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.15%. For the same industry, the average monthly price growth was -3.02%, and the average quarterly price growth was +22.32%.
DCGO is expected to report earnings on Nov 09, 2026.
USPH is expected to report earnings on Nov 04, 2026.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor indicates that over the last year, DCGO has been loosely correlated with NHC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if DCGO jumps, then NHC could also see price increases.
| Ticker / NAME | Correlation To DCGO | 1D Price Change % | ||
|---|---|---|---|---|
| DCGO | 100% | +1.69% | ||
| NHC - DCGO | 33% Loosely correlated | +3.17% | ||
| USPH - DCGO | 31% Poorly correlated | +2.84% | ||
| GRDN - DCGO | 24% Poorly correlated | +1.56% | ||
| ARDT - DCGO | 23% Poorly correlated | +2.49% | ||
| JYNT - DCGO | 22% Poorly correlated | +2.79% | ||
More | ||||